Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/06 → 5/31/08 |
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Induction Study to Assess the Efficacy and Safety of 6ug Sargramostim (Leukine) Administered Subcutaneously once daily for 8 weeks in patients with Active Crohn's Disease
- De Villiers, Willem (PI)